AXGN - AxoGen Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 BTCUSD (%) AMD (3.15%) ADAUSD (%) WMT (0.22%) V (-0.62%) TLRY (-5.26%) SQQQ (1.59%) RIOT (3.3%) MARA (0.55%) LINKUSD (%) LC (1.59%) JPM (-0.8%) INMD (-2.04%) F (-3.06%) ETHUSD (%) CAKE (-5.2%)

AXGN - AxoGen

$20.37 0.17[0.85%]

15 mins delayed data

People also watch : TMO | BSX | MDT

+Watchlist

3 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$20.20	Open	$20.09
Volume	108.5K	Market Cap	791.79M
Yield		Last Dividend

Day

52 Week

Axogen, Inc. to Present at the Canaccord...	07/22/21
ALACHUA, Fla. and TAMPA, Fla., July 22, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative ...

Axogen, Inc. Appoints John H. Johnson to...	07/19/21
Global leader brings 30+ years of biopharma experience to Axogen, Inc. Board of Directors Global leader brings 30+ years of biopharma experience to Ax...

Nerve Repair and Re-generation Biomateri...	07/18/21
Nerve Repair and Re-generation Biomaterials Market research is an intelligence report with meticulous efforts undertaken to study the right and valua...

Axogen, Inc. to Report Second Quarter Fi...	07/14/21
ALACHUA, Fla. and TAMPA, Fla., July 14, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative s...

Tissue Growth: Axogens Biologic Transiti...	06/24/21
Axogen plans to process only human nerve tissue for Avance and other products at the new facility, which is being built to cGMP standards, and is inte...

Meet Pete Mariani, a 2021 CFO of the Yea...	06/01/21
Peter Mariani is the executive vice president and chief financial officer of Axogen.

AxoGen (AXGN) Receives a Buy from Leerin...	05/31/21
In a report issued on May 26, Richard Newitter from Leerink Partners maintained a Buy rating on AxoGen (AXGN), with a price target The post AxoGen (A...

Canaccord Genuity Keeps a Hold Rating on...	05/25/21
In a report released yesterday, Kyle Rose from Canaccord Genuity maintained a Hold rating on AxoGen (AXGN), with a price target of $24.00. The post Ca...

AxoGen (AXGN) Investor Presentation - Sl...	05/24/21
No summary available.

Axogen To Stop Commercial Sales Of Avive...	05/18/21
Axogen Inc (NASDAQ: AXGN ) has announced to suspend the market availability of Avive Soft Tissue Membrane (Avive) effective June 1, pending ongoing di...

AxoGen reiterates 2021 guidance despite ...	05/18/21
No summary available.

AxoGen (AXGN) Gets a Hold Rating from BT...	05/18/21
BTIG analyst Ryan Zimmerman maintained a Hold rating on AxoGen (AXGN) today. The companys shares closed last Monday at $21. The post AxoGen (AXGN) Get...

Axogen, Inc. to present at the Jefferies...	05/17/21
Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced th...

Axogen Inc. Shares Near 52-Week High - M...	02/04/21
Axogen Inc. shares closed today at 1.4% below its 52 week high of $20.09, giving the company a market cap of $804M. The stock is currently up 10.7% y...

Axogen Inc. Shares Approach 52-Week High...	01/11/21
Axogen Inc. shares closed today at just slightly below its 52 week high of $20.09, giving the company a market cap of $815M. The stock is currently u...

Axogen Inc. Shares Climb 3.8% Past Previ...	01/05/21
Axogen Inc. shares closed 3.8% higher than its previous 52 week high, giving the company a market cap of $722M. The stock is currently up 0.6% year-t...

ANALYST RATINGS

2 analyst ratings (Last 3 months)

50.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $AXGN

Service Name	Trader	% Success
Alpha Swing Trades	Jonathan	68.00 %	Follow
FEAT. MARVIN GAYE	JOHN KROLIKOWSKI JR	57.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.